Association between skeletal muscle fat content and very-low-density lipoprotein-apolipoprotein B-100 transport in obesity: Effect of weight loss

Diabetes, Obesity and Metabolism

Volumn 16, Issue 10, 2014, Pages 994-1000

  Chan, Dick C ^a   Gan, S K ^a   Wong, A T Y ^a   Barrett, P H R ^a   Watts, G F ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Dyslipidaemia; Ectopic fat; Lipoprotein metabolism; Obesity

Indexed keywords

APOLIPOPROTEIN B100; FAT; GLUCOSE; INSULIN; STABLE ISOTOPE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ABDOMINAL FAT; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CATABOLISM; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONCENTRATION PROCESS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; ENZYME KINETICS; FAT CONTENT; FATTY ACID BLOOD LEVEL; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID METABOLISM; LIPID STORAGE; LIPOPROTEIN SECRETION; LOW FAT DIET; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PROTEIN TRANSPORT; SEX DIFFERENCE; SKELETAL MUSCLE; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; BLOOD; COMPLICATION; LIVER; METABOLISM; MIDDLE AGED; SECRETION (PROCESS); TRANSPORT AT THE CELLULAR LEVEL;

APOLIPOPROTEIN B-100; BIOLOGICAL TRANSPORT; DIET, FAT-RESTRICTED; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPOPROTEINS, VLDL; LIVER; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY; TRIGLYCERIDES; WEIGHT LOSS;

EID: 84912529041     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12311     Document Type: Article

References (20)

1. Després JP, Lemieux I, Bergeron J et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008; 28: 1039-1049.
2. Kelley DE, Goodpaster BH. Skeletal muscle triglyceride: an aspect of regional adiposity and insulin resistance. Diabetes Care 2001; 24: 933-941.
3. Brons C, Vaag A. Skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes. J Physiol 2009; 587: 3977-3978.
4. Chan DC, Watts GF, Gan SK, Wong ATY, Ooi EMM, Barrett PHR. Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-lowdensity lipoprotein-apolipoprotein B-100 in obesity. Arterioscler Thromb Vasc Biol 2010; 30: 1043-1050.
5. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985; 41: 810-817.
6. Chan DC, Watts GF, Ng TW, Hua J, Song S, Barrett PHR. Measurement of liver fat by magnetic resonance imaging: relationships with body fat distribution, insulin sensitivity and plasma lipids in healthy men. Diabetes Obes Metab 2006; 8: 698-702.
7. Gan SK, Kriketos AD, Poynten AM et al. Insulin action, regional fat, and myocyte lipid: altered relationships with increased adiposity. Obes Res 2003; 11: 1295-1305.
8. Beghin L, Duhal N, Poulain P et al. Measurement of apolipoprotein B concentration in plasma lipoproteins by combining selective precipitation and mass spectrometry. J Lipid Res 2000; 41: 1172-1176.
9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
10. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 2003; 26: 3320-3325.
11. Watts GF, Riches FM, Kelly JM, Powell MA, Croft KD. Determinants of the kinetics of very-low density lipoprotein apolipoprotein B-100 in non-obese men. Clin Exp Pharmacol Physiol 1997; 24: 556-562.
12. Ng TWK, Watts GF, Farvid MS, Chan DC, Barrett PHR. Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics? Diabetes 2005; 54: 795-802.
13. Adiels M, Taskinen MR, Packard C et al. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 2006; 49: 755-765.
14. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000; 21: 697-738.
15. Ginsberg HN, Huang LS. The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis. J Cardiovasc Risk 2000; 7: 325-331.
16. van Gaal L, Wauters M, De Leeuw I. The beneficial effects of modest weight loss on cardiovascular risk factors. Int J Obes Relat Metab Disord 1997; 21(Suppl 1): S5-S9.
17. Ahmed MH, Byrne CD. Current treatment of non-alcoholic fatty liver disease. Diabetes Obes Metab 2009; 11: 188-195.
18. Goodpaste BH, Thaete FL, Kelley DE. Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am J Clin Nutr 2000; 71: 885-892.
19. Goodpaster BH, Kelley DE, Thaete FL, He J, Ross R. Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol 2000; 89: 104-110.
20. Kiens B. Skeletalmuscle lipid metabolism in exercise and insulin resistance. Physiol Rev 2006; 86: 205-243.